DexCom Revenue decreased by 5.4% to $1.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from $1.04B to $1.19B. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 17.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $595.10M | $650.20M | $698.20M | $628.80M | $696.20M | $769.60M | $815.20M | $741.50M | $871.30M | $975.00M | $1.03B | $921.00M | $1.00B | $994.20M | $1.11B | $1.04B | $1.16B | $1.21B | $1.26B | $1.19B |
| QoQ Change | — | +9.3% | +7.4% | -9.9% | +10.7% | +10.5% | +5.9% | -9.0% | +17.5% | +11.9% | +6.1% | -11.0% | +9.0% | -1.0% | +12.0% | -7.0% | +11.7% | +4.5% | +4.2% | -5.4% |
| YoY Change | — | — | — | — | +17.0% | +18.4% | +16.8% | +17.9% | +25.2% | +26.7% | +26.9% | +24.2% | +15.3% | +2.0% | +7.6% | +12.5% | +15.2% | +21.6% | +13.1% | +15.0% |